AIarXiv

Ranked by formulaVerdict: Notable

BRIDGE: An Acceptance Gate to Block False Improvements in Model Updates, with a Retrospective Clinical Evaluation

Models are updated repeatedly, and an update that looks better on validation data but not on new data is a false improvement that can misguide clinical decisions.

By Sunaryono

Score████░░░░░░3.9

Key numbers

  • 3.1 times the naive rule
  • 20.7% to 1.7%
  • 20.0% to 0%

Caveats

  • Preprint; not yet peer reviewed.

VerdictWorth a reader's time today.

Read the originalPDF

Abstract

Models are updated repeatedly, and an update that looks better on validation data but not on new data is a false improvement that can misguide clinical decisions. The naive rule accepts every positive validation gain and is optimistic when the same data choose and judge the update. BRIDGE is a model-agnostic acceptance gate that decides each update from predictions and the available labels, with fixed settings. Each fold of the data judges the update chosen on the other folds (cross-fitting) to reduce selection bias; acceptance requires the gain's lower bootstrap bound to exceed a margin. The four settings are (A) 11 new datasets, (B) synthetic tasks, (C) 12 retrospective clinical tasks, and (D) 39 supporting datasets. The false-improvement rate falls from 19.1% (naive) to 1.1% (BRIDGE) in (A), 20.7% to 1.7% (B), 20.0% to 0% (C), and 12.5% to 0.5% (D); every 95% confidence interval of the reduction over datasets or tasks excludes zero (not over the clinical sources). An equal-size random draw from the naive acceptances contains more false improvements in (A)-(E) (post hoc, p<0.001). On the OpenML collection (E) of 14 new datasets, the false-improvement rate falls from 25.6% to 1.0%. BRIDGE removes 97% to 100% of the false improvements that the naive rule accepts, and its mean gain per deployed update is 1.8 to 3.1 times the naive rule's. The 95% upper bound on the false-improvement rate is below 5.5%: formal in (B) for independent tasks (3.56%), and conditional on the real data tested (0.33% to 5.40%).

Dwi Sunaryono

The editor's rubric

Heuristic review

Leverage3 / 5
A method or resource many groups across the field will adopt within a year.
24% of this desk’s rubric
Magnitude4 / 5
A qualitative jump: a capability or regime that did not exist before.
18% of this desk’s rubric
Evidence3 / 5
Solid: multiple benchmarks or cohorts, ablations, fair baselines, released code or data.
14% of this desk’s rubric
Novelty2 / 5
A new combination of known ideas.
16% of this desk’s rubric
Trajectory2 / 5
Some room to improve with obvious engineering.
18% of this desk’s rubric
Stakes2 / 5
Benefits a professional community (practitioners, clinicians, engineers).
10% of this desk’s rubric

Editor’s rationale

Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: breadth (many tasks); gains (x-fold, relative gain, outperforms); verification (confidence interval, p-value, multiple benchmarks). Red flags: weak evidence (single site).

How the score was computed

rank-2026-10-18

Score████░░░░░░3.9

Score = 10 × (65% × adjusted merit / 10 + 25% × attention + 10% × freshness)

Desks place stronger verdicts first, then use this score to order work within the same verdict.

Merit
5.5 / 10
Weighted rubric, evidence-gated.
Adjusted merit
4.7 / 10
Shrunk toward the desk prior by editor confidence (46%).
Attention
0%
Citations, upvotes, points, mentions.
Freshness
83%
Half-life decay since publication.

No attention signals recorded yet.

The record

  • Reviewed by heuristic-v7 on Oct 22, 2026, 01:55 UTC. Paper type: theory.
  • Categories: cs.LG, stat.ML
  • BRIEF, No.3 in the Medicine edition of October 22, 2026.